You are viewing an incomplete version of our website. Please click to reload the website as full version.

ATP13A2 antibody (ATPase Type 13A2) (C-Term)

Details for Product anti-ATP13A2 Antibody No. ABIN950560, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms RGD1307977, ATP13A2, im:7147302, zgc:136762, CLN12, HSA9947, KRPPD, PARK9, 1110012E06Rik, AA589443
C-Term, AA 1132-1161
(13), (13), (3), (2), (2), (1), (1), (1), (1), (1), (1)
(41), (16), (14)
(37), (6)
This ATP13A2 antibody is un-conjugated
(3), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Enzyme Immunoassay (EIA), Western Blotting (WB)
(27), (19), (11), (6), (3), (2), (1)
Pubmed 5 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 0.4 mL
Shipping to United States ( )
Availability Will be delivered in 6 to 8 Business Days
Immunogen KLH conjugated synthetic peptide between 1132-1161 amino acids from the C-terminal region of human ATP13A2
Isotype Ig
Specificity This antibody reacts to ATP13A2.
Cross-Reactivity (Details) Species reactivity (tested):Human.
Purification Affinity chromatography on Protein A
Alternative Name ATP13A2 / PARK9 (ATP13A2 Antibody Abstract)
Background This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.Synonyms: Probable cation-transporting ATPase 13A2
Gene ID 23400
NCBI Accession NP_001135446
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Concentration 0.25 mg/mL
Buffer PBS containing 0.09 % (W/V) sodium azide as preservative
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Supplier Images
Western Blotting (WB) image for anti-ATP13A2 antibody (ATPase Type 13A2) (C-Term) (ABIN950560) ATP13A2 Antibody (C-term) western blot analysis in U251 cell line lysates (35µg/lane)...
Background publications Dos Santos, Pestana, Diniz et al.: "Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease." in: Neuroscience letters, Vol. 485, Issue 2, pp. 121-4, 2010 (PubMed).

Reetz, Tadic, Kasten et al.: "Structural imaging in the presymptomatic stage of genetically determined parkinsonism." in: Neurobiology of disease, Vol. 39, Issue 3, pp. 402-8, 2010 (PubMed).

Schneider, Paisan-Ruiz, Quinn et al.: "ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation." in: Movement disorders : official journal of the Movement Disorder Society, Vol. 25, Issue 8, pp. 979-84, 2010 (PubMed).

Fei, Cao, Xiao et al.: "Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China." in: Neuroscience letters, Vol. 475, Issue 2, pp. 61-3, 2010 (PubMed).

Okada, Kamatani, Takahashi et al.: "A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci." in: Human molecular genetics, Vol. 19, Issue 11, pp. 2303-12, 2010 (PubMed).

Catalog No. ABIN950560
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)